Mohsen MO - Search Results

1

Intranodal Injection of Immune Activator Demonstrates Antitumor Efficacy in an Adjuvant Approach.

Josi R, Ogrina A, Rothen D, Balke I, Casaramona AS, de Brot S, Mohsen MO. Josi R, et al. Among authors: mohsen mo. Vaccines (Basel). 2024 Mar 26;12(4):355. doi: 10.3390/vaccines12040355. Vaccines (Basel). 2024. PMID: 38675737 Free PMC article.

2

Regulation of pulmonary plasma cell responses during secondary infection with influenza virus.

MacLean AJ, Bonifacio JPPL, Oram SL, Mohsen MO, Bachmann MF, Arnon TI. MacLean AJ, et al. Among authors: mohsen mo. J Exp Med. 2024 Jul 1;221(7):e20232014. doi: 10.1084/jem.20232014. Epub 2024 Apr 25. J Exp Med. 2024. PMID: 38661717 Free PMC article.

3

A tetravalent nanovaccine that inhibits growth of HPV-associated head and neck carcinoma via dendritic and T cell activation.

Josi R, Speiser DE, de Brot S, Vogt AC, Sevick-Muraca EM, Tolstonog GV, Bachmann MF, Mohsen MO. Josi R, et al. Among authors: mohsen mo. iScience. 2024 Mar 6;27(4):109439. doi: 10.1016/j.isci.2024.109439. eCollection 2024 Apr 19. iScience. 2024. PMID: 38523774 Free PMC article.

4

The next generation virus-like particle platform for the treatment of peanut allergy.

Sobczak JM, Krenger PS, Storni F, Mohsen MO, Balke I, Reseviča G, Heath MD, Carreno Velazquez TL, Kramer MF, Scott CJW, Skinner MA, Zeltiņš A, Kündig TM, Vogel M, Bachmann MF. Sobczak JM, et al. Among authors: mohsen mo. Allergy. 2023 Jul;78(7):1980-1996. doi: 10.1111/all.15704. Epub 2023 Mar 29. Allergy. 2023. PMID: 36883475 Free article.

5

Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation.

Chang X, Liu X, Martina B, Zeltins A, Augusto G, Vogel M, Mohsen MO, Speiser DE, Bachmann MF. Chang X, et al. Among authors: mohsen mo. Front Immunol. 2023 Feb 10;14:1114396. doi: 10.3389/fimmu.2023.1114396. eCollection 2023. Front Immunol. 2023. PMID: 36845100 Free PMC article.

6

Alzheimer's Disease: A Brief History of Immunotherapies Targeting Amyloid β.

Vogt AS, Jennings GT, Mohsen MO, Vogel M, Bachmann MF. Vogt AS, et al. Among authors: mohsen mo. Int J Mol Sci. 2023 Feb 15;24(4):3895. doi: 10.3390/ijms24043895. Int J Mol Sci. 2023. PMID: 36835301 Free PMC article. Review.

7

In situ delivery of nanoparticles formulated with micron-sized crystals protects from murine melanoma.

Mohsen MO, Heath M, Kramer MF, Velazquez TC, Bullimore A, Skinner MA, Speiser DE, Bachmann MF. Mohsen MO, et al. J Immunother Cancer. 2022 Sep;10(9):e004643. doi: 10.1136/jitc-2022-004643. J Immunother Cancer. 2022. PMID: 36100311 Free PMC article.

8

Virus-like particle vaccinology, from bench to bedside.

Mohsen MO, Bachmann MF. Mohsen MO, et al. Cell Mol Immunol. 2022 Sep;19(9):993-1011. doi: 10.1038/s41423-022-00897-8. Epub 2022 Aug 12. Cell Mol Immunol. 2022. PMID: 35962190 Free PMC article. Review.

9

Virus-Like Particles Are Efficient Tools for Boosting mRNA-Induced Antibodies.

Vogt AS, Jörg L, Martina B, Krenger PS, Chang X, Zeltins A, Vogel M, Mohsen MO, Bachmann MF. Vogt AS, et al. Among authors: mohsen mo. Front Immunol. 2022 Jun 16;13:864718. doi: 10.3389/fimmu.2022.864718. eCollection 2022. Front Immunol. 2022. PMID: 35784292 Free PMC article.

10

Increased Receptor Affinity and Reduced Recognition by Specific Antibodies Contribute to Immune Escape of SARS-CoV-2 Variant Omicron.

Vogt AS, Augusto G, Martina B, Chang X, Nasrallah G, Speiser DE, Vogel M, Bachmann MF, Mohsen MO. Vogt AS, et al. Among authors: mohsen mo. Vaccines (Basel). 2022 May 9;10(5):743. doi: 10.3390/vaccines10050743. Vaccines (Basel). 2022. PMID: 35632499 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

52 results

Search Page